NRL Pharma, Inc.
Records under this name other than patents NRL Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to NRL Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,562,959 | Lactoferrin fusion protein and method for preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,809,641 | Lactoferrin fusion protein and method for preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,041,014 | Lactoferrin/albumin fusion protein and production method therefor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,968,186 | Ascochlorin derivative and use thereof as AMPK activator Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,399,414 | Analgesics Term ended Term ended Jan 17, 2023 · From the USPTO record | Term ended | Term ended Jan 17, 2023 | From the USPTO record |
| US 8,673,839 | Lactoferrin complex and method of producing the same Lapsed on the fee record Ended Mar 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2022 | From the USPTO record |
| US 7,629,471 | Transcriptional factor, process for producing the same and use thereof Lapsed on the fee record Ended Dec 8, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2021 | From the USPTO record |
| US 7,432,306 | Method for preparing novel transcription factors and use Lapsed on the fee record Ended Oct 7, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2020 | From the USPTO record |